Problem {#s1}
=======

The U.S. Centers for Disease Control and Prevention (CDC) has stated that eliminating healthcare-associated infections (HAIs) is a 'Winnable Battle' because interventions exist to mitigate public health impact.[@R1] Surveillance for one type of HAI, ventilator-associated pneumonia (VAP), was challenging due to the absence of a consistent, objective definition for VAP, so in 2013, the CDC launched a new case definition using readily obtainable data: the ventilator-associated event (VAE). VAEs are sustained increases in oxygenation needs of a patient on mechanical ventilation (MV) following a period of stability or improvement and have been associated with longer intensive care unit (ICU) and hospital lengths of stay and higher mortality.[@R2] VAEs may not be completely preventable, although decreasing MV exposure with ventilator weaning practices is recommended.[@R5] Patients must be ventilated for at least four calendar days to fulfil VAE criteria.[@R6]

The U.S. Department of Veterans Affairs (VA) assesses performance at VA medical centres using a scorecard of measures called Strategic Analytics for Improvement and Learning (SAIL); it includes VAEs with other HAIs in the 'avoidable adverse events' domain of its quarterly reports.[@R7] In October 2016, VA Greater Los Angeles (GLA) ranked in the bottom decile of all VA medical centres in overall SAIL performance, and GLA leadership selected HAIs as one of six targets for improvement. We focused on VAEs since their incidence (6.8 events per 1000 ventilator days in the 18 months preceding our intervention) was worst of all HAI measures based on the VAE benchmark of zero events in all VA medical centres nationally.[@R7]

At the time of our project, all MV patients at GLA were admitted to a 22-bed combined medical/surgical ICU where they received care from multidisciplinary teams consisting of physicians, nurses and respiratory therapists (RTs), among others. Coordinating these providers for ventilator weaning was difficult because of frequent resident and nurse turnover and limited RT availability. GLA is affiliated with several residency programmes from nearby universities, so residents may have spent only 4 weeks at GLA over an academic year. Although nurses' presence was more stable relative to residents, GLA experienced high nursing staff turnover and hired a new ICU nurse manager in September 2016. RTs caring for MV patients had simultaneous assignments in other non-ICU areas of the hospital but were available by pager.

Non-personnel factors also affected ventilator processes. The ICU case severity index, a measure of illness severity with higher indices reflecting a higher proportion of more critically ill patients, was higher at GLA than other VA medical centres in southern California. Conversely, the ventilator utilisation ratio (ie, ventilator days divided by ICU bed days) of 0.27 was below the nationwide VA system average (0.34, 0.25 and 0.18 were the 50th, 25th and 10th percentiles, respectively, based on the latest available national data from 2014)[@R8] and half of MV patients on average had sedative infusion orders. While having and sedating fewer MV patients may decrease VAE risk at the unit level, these practices reduce opportunities to standardise ventilator weaning for individual MV patients.

Our specific aim was to decrease average MV duration of patients with acute respiratory failure (ARF) to less than 3 days (from a baseline of 7.2 days) by 1 July 2017.

Background {#s2}
==========

Evidence for VAE prevention comes mostly from observational studies. In their 2014 guideline update, the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) recommended adopting VAP prevention strategies to also prevent VAEs, including daily sedation interruptions in spontaneous awakening trials (SATs) and daily assessments of extubation readiness in spontaneous breathing trials (SBTs) to decrease MV duration.[@R5] Because acute respiratory distress syndrome, fluid overload and haemorrhage can cause VAEs, some experts suggest low tidal volume ventilation, conservative fluid management and conservative transfusion thresholds as additional prevention strategies.[@R3] One retrospective cohort study in 2015 found significant associations between SATs, SBTs, head of bed elevation, thromboembolism prophylaxis and chlorhexidine oral care with shorter time to extubation and lower on-ventilator mortality, but only SBTs were associated with decreased VAE likelihood.[@R10]

Although IDSA/SHEA guidelines suggest bundling interventions to improve compliance with these practices,[@R5] literature on implementing ventilator bundles is mixed.[@R11] Improvement teams in two Scottish ICUs reduced VAP rates in both hospitals using different strategies; one changed workflows to close communication gaps between providers, while the other used key opinion leaders and huddles to reinforce desired behaviours.[@R16] In 2007, a systematic review of VAP prevention studies showed decreased VAP rates in several ICUs in the USA, Argentina and Pakistan through implementation of similar educational programmes combined with surveillance feedback.[@R17] In these studies, however, baseline VAP rates were fairly high, ranging from 7.5 to 51.3 infections per 1000 ventilator days. A cluster-randomised trial of 60 ICUs in the USA (with median baseline VAP rate of 2.9 infections per 1000 ventilator days) compared a toolkit with a virtual collaborative implementation strategy to reduce VAP. Although ICUs in the virtual collaborative group implemented ventilator bundles more often, there was no difference in VAP rates between the groups after 18 months.[@R18] The gap between guidelines and effective implementation strategies is widely recognised.[@R13] Nonetheless, in our case, the imperative for improvement was strong enough to proceed with guideline-concordant strategies.

Measurement {#s3}
===========

Our overall goal was to reduce VAE incidence (ie, number of VAEs divided by ventilator days); however, due to the relative rarity of VAEs, using VAE incidence as our primary measure of improvement was not ideal. We instead used MV duration as a proxy. Based on studies that used MV duration as an outcome, average MV duration ranges from 1.5 to 7.9 days.[@R20] Our goal MV duration of less than 3 days was based on the VAE definition since no optimal threshold exists. Patients who meet this goal effectively can only improve the VAE incidence by contributing solely to the denominator; by definition, VAEs occur only in patients intubated for at least four calendar days. However, our objective of reducing MV duration was primarily motivated by the intent to reduce HAIs by minimising exposure to devices (ie, central lines, indwelling urinary catheters and ventilators).

We defined our primary outcome, MV duration, as the number of calendar days from intubation to extubation. If a patient was intubated on the evening of 1 January and extubated on the morning of 2 January, we counted this as two calendar days. Reintubations were treated as separate episodes; if a patient was intubated from 1 January to 3 January and had to be reintubated from 11 January to 13 January, we counted this as two occurrences of three calendar days of MV. We aggregated data as monthly averages on a run chart and as quarterly averages on an XbarS chart; the run chart allowed us to more quickly identify special cause variation signals and the XbarS chart allowed us to smooth month-to-month variation. Theoretically, it is possible to have the same average MV duration in two different months, with 1 month having greater overall VAE risk (eg, with 100 patients each intubated for 4 days) and the other month having lower overall VAE risk (eg, with a single patient intubated for 4 days), implying that MV duration is not a direct proxy for VAE risk. We accepted this shortcoming since our interventions mitigated patient-level rather than unit-level VAE risk. Number of calendar days between VAEs was plotted on a t chart as a secondary outcome. Balancing measures included the monthly number of MV patients (to capture reintubations), ICU case severity index and ventilator utilisation ratio, which we plotted on XmR charts and a p chart.

For our process measures, we chose proportions of SAT-eligible and SBT-eligible patients with the corresponding order for SAT or SBT present. To be eligible for an SAT order, a patient needed a sedative infusion (eg, midazolam, lorazepam, propofol and dexmedetomidine) ordered for at least 24 hours; to be eligible for an SBT order, a patient needed to be on MV for at least two calendar days. Orders were considered present if entered during the MV episode. We aggregated process measure data monthly on p charts.

We obtained data from monthly retrospective chart reviews of MV patients and grouped measurements into three periods: baseline (May 2015 to October 2016), period 1 (following our first intervention, November 2016 to March 2017) and period 2 (following our second intervention, April 2017 to December 2017). We used QI Macros 2017 to build and analyse our charts; for all charts, we 'froze' the central line (ie, median for run chart and mean for statistical process control charts) from the baseline period to more accurately detect special cause variation signals according to the Westgard rules and treated periods 1 and 2 together as the intervention period.[@R25] We supplemented our chart analysis with classical parametric statistics using STATA/IC V.14.2. We excluded patients recovering postoperatively from anaesthesia or with long-term ventilator dependence (ie, did not have ARF) as they are not generally sedated or placed on SBTs for ventilator weaning.

Design {#s4}
======

The GLA Institutional Review Board determined this project to be quality improvement, non-research activity.

Our improvement team convened in October 2016 and included the medical and surgical ICU directors, chief medical/surgical nurse, ICU nurse manager, RT director, inpatient pharmacy manager, infection control staff, workgroup chairs and quality improvement fellow (author MMC). We first reviewed charts for all nine patients who had VAEs in 2016 to identify systemic issues. Documentation of worsening oxygenation in progress notes was sparse and, when present, insufficient to infer root causes. Most VAEs occurred in medical ICU patients, and all but one patient was intubated for more than 7 days before the VAE occurred. Because we did not discover a root cause from this investigation, we proceeded to determine our compliance with consensus guidelines described previously.

Nearly a decade before beginning this project, the medical ICU director and Critical Care Committee designed a ventilator bundle order set in our electronic medical record (EMR) that grouped IDSA/SHEA-recommended VAP prevention strategies (ie, SAT, SBT, head of bed elevation, chlorhexidine oral care, and stress ulcer and thromboembolism prophylaxis) with medication orders commonly used for intubated patients (ie, sedation and analgesia drips, as-needed delirium medications and enteral nutrition orders). A spot check of MV patients in October 2016 showed order set underutilisation. Insufficient education and lack of emphasis on bundle compliance explained this finding; residents rotate through the ICU for short periods with brief orientations. Furthermore, we found the order set cumbersome to use; ventilator settings were featured at the end of the order set with the intention to oblige residents to order nine other ventilator care elements, including ones with less evidence or duplicates from other order sets. Technical limitations in our EMR when the order set was originally coded also disrupted the order set's flow.

Our first intervention (period 1) was to address the residents' knowledge gap. The medical and surgical ICU directors requested their attending physicians, when on service, to train residents on using the order set to improve bundle compliance. We expected this intervention to change the residents' behaviours and improve bundle use through education and also by expectation-setting and influence of authority. To address the order set's usability, we simultaneously began revising its content and layout for our second intervention (period 2); we sought to create a convenient and streamlined 'one-stop shop' that would suit the needs of a heterogeneous group of residents.

Strategy {#s5}
========

We implemented the educational directive of period 1 in November 2016. Because SATs and SBTs were intermittently performed during daily rounds, attending physicians had been unaware that ventilator bundles were not being ordered. Within the first week, a follow-up spot check showed more MV patients with bundle orders.

For the period 2 intervention, we created several workgroups to individually address various components of the order set; the workgroups later met together to address all operational elements in the order set, clarifying the responsibilities of each provider (eg, physician, nurse, RT) to ensure seamless transitions. A primary goal was reorganising the order set visually with prominent display of 'mandatory' guideline-based practices (ie, SATs and SBTs). Once the clinical informatics team began building revisions, the order set underwent many iterations with feedback from the quality improvement fellow, the medical ICU director and a clinical informatics specialist who was formerly an ICU nurse; all tested the order set on fictitious patients in the EMR before settling on a final product (online [supplemental figures 1A-1E](#SP1 SP2 SP3 SP4 SP5){ref-type="supplementary-material"}).

While updating SAT and SBT orders in the order set, we learnt there was no standardised approach to operationalise SATs and SBTs. Orders were delivered inconsistently; some were verbal, and others were electronic. In February 2017, bedside audits showed that for 7 of 15 patients, SATs and SBTs were performed without corresponding electronic orders. Our medical ICU director and RTs had approved an SBT protocol in 2013; some RTs were unaware of its existence, while others felt disempowered to use it because of frequently conflicting verbal physician orders, leading them to wait for explicit approval from attending physicians to initiate the SBT protocol during morning rounds. In contrast, nurses had never established an SAT protocol. These inconsistencies in order entry and actualisation along with differing physician practices introduced variation into the MV care process that could cause higher MV duration and thereby VAE incidence; standardising that process would be critical to achieving success with the ventilator bundle. Thus, the ICU nurse manager and two bedside nurses worked together to establish a step-by-step process that would fit into their workflow and facilitate SBTs, which require sedation to be held. They adapted a protocol from another hospital and condensed the pathway to two steps: check for SAT exclusion criteria (ie, seizures, drug withdrawal, high risk for ventilator-related injury, fraction of inspired oxygen greater than 0.70, vasopressor dose equal to or greater than 10 µg/kg/min, and concurrent paralytic infusion) and hold the sedative at the appropriate time (either 6:00 or 8:00) based on its duration of effect. We simplified the SBT protocol to include only parameters RTs routinely assessed. Contraindications for SBTs included concurrent sedative, analgesic or paralytic infusions; haemodynamic instability; oxygen saturation less than 92%; positive end-expiratory pressure greater than 5 mm Hg; fraction of inspired oxygen greater than 0.40; pH less than 7.3; and minute ventilation greater than 15 L/min. We added the new SAT and updated SBT protocols to the order set.

In mapping SAT and SBT flow, we felt the configuration of RT staffing at the time would impede successful deployment of the ventilator bundle and therefore facilitated around-the-clock RT staffing in the ICU. Because RTs had not been physically present in the ICU at all hours, physicians were adjusting ventilator settings, making streamlining of ventilator weaning more challenging. To transition to the new staffing model of around-the-clock in-unit coverage, GLA's chief of staff negotiated the addition of contractual RT staff, although several full-time RTs ultimately volunteered for ICU shifts.

Thus, to our planned order set revision, we added corresponding nurse-driven and RT-driven SAT and SBT protocols and stationing RTs in the ICU for 24-hour coverage for our period 2 intervention. All components were ready for implementation in April 2017. Our primary implementation strategy for these changes was education, with all ICU staff receiving education on the revised order set and protocols from their respective leaders (ie, the medical and surgical ICU directors, ICU nurse educator and RT director) on our improvement team. We designed and distributed badge and pocket cards to illustrate and remind providers of the process changes ([online supplementary figures 2 and 3](#SP6 SP7){ref-type="supplementary-material"}). The quality improvement fellow attended a resident orientation to demonstrate use of the order set; she also went to a nurse huddle to review the new SAT protocol.

Results {#s6}
=======

There was a shift of 14 data points above the central line in both p charts of SAT and SBT order entry that began in November 2016, corresponding with period 1 ([figure 1](#F1){ref-type="fig"}). At baseline, SAT and SBT order entry (ie, percentage of eligible patients with orders) averaged 29.9% and 51.2%, respectively; after the shift in November 2016, they averaged 67.9% and 77.7%, respectively. Improvement was sustained for both measures at the end of December 2017.

![P chart of percentage of eligible patients with spontaneous awakening trial (SAT) and spontaneous breathing trial (SBT) orders. Data plotted in dark blue with shift following intervention (11--16) highlighted in red. Central line (mean) in light blue. Upper and lower control limits in grey (dashed). Start of period 1 at solid arrow. Start of period 2 at dashed arrow. Interrupted time-series analysis comparison of baseline with periods 1 and 2 significant at p=0.002 for SAT order entry and p=0.013 for SBT order entry (for coefficient indicating immediate effect of intervention).](bmjoq-2018-000426f01){#F1}

There were no special cause variation signals on the run chart of monthly MV duration, although the run chart over its entire period (May 2015 to December 2017) exhibits a general downward trend ([figure 2](#F2){ref-type="fig"}). During the baseline period, the median monthly MV duration was 6.5 days (range 4.1--15.1 days); during periods 1 and 2, it was 4.8 days (range 3.7--8.9 days) at the end of December 2017. Similarly, on the XbarS chart of quarterly MV duration, which spans October 2013 to December 2017, there are no special cause signals corresponding with our interventions, but there is an 8-point downward shift that begins in the first quarter of 2016 (ie, October 2015 to December 2015) a year before our intervention began ([online supplementary figure 4](#SP8){ref-type="supplementary-material"}). There are several special cause signals suggesting decreased variation on the S portion of the XbarS chart corresponding with period 1.
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![Run chart of mechanical ventilation (MV) duration aggregated monthly. Data plotted in dark blue. Central line (median) in light blue. Goal line in green. Start of period 1 at solid arrow. Start of period 2 at dashed arrow. Interrupted time-series analysis comparison of baseline with periods 1 and 2 non-significant (p=0.590 for coefficient indicating immediate effect of intervention; p=0.588 for coefficient indicating trend following intervention).](bmjoq-2018-000426f02){#F2}

From October 2016 to December 2017, there were six VAEs with no systemic issues found after chart review. There was a statistically non-significant decrease in VAE rate from 6.8 events per 1000 ventilator days (5.2 events per 100 ventilated patients) at baseline to 1.3 events per 1000 ventilator days (0.7 events per 100 ventilated patients) during period 2. There were no special cause signals on the t chart of calendar days between VAEs ([online supplementary figure 5](#SP9){ref-type="supplementary-material"}). During the baseline period, the time between VAEs averaged 31.4 days (range 0 to 109 days); during periods 1 and 2, it averaged 73.4 days (range 8 to 198 days) at the end of December 2017.
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On the XmR chart of number of MV patients per month, there is one data point (June 2017) that is above the upper control limit; however, there are no other special cause signals (see [online supplementary figure 6](#SP10){ref-type="supplementary-material"}). The number of MV patients per month averaged 16.2 patients (range 6--27 patients) between May 2015 and December 2017. There were no special cause signals on the XmR chart of ICU case severity index ([online supplementary figure 7](#SP11){ref-type="supplementary-material"}). There were special cause signals (data points below or above lower or upper control limits) on the p chart of ventilator utilisation ratio, but none were sustained or clearly attributable to our intervention ([online supplementary figure 8](#SP12){ref-type="supplementary-material"}).
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Results based on classical parametric statistics are presented in [table 1](#T1){ref-type="table"}. Findings are overall similar to chart analysis, showing statistically significant increases in SAT and SBT order entry in periods 1 and 2 and a decrease in ventilator utilisation ratio in period 2, with the additional finding of a statistically significant difference in MV duration between baseline and period 2 (p=0.049).

###### 

Summary of findings

  --------------------------------------------------------------------------------------------------------------------------
                                             Baseline\       Period 1\                       Period 2\
                                             (May 2015 to\   (November 2016 to March 2017)   (April 2017 to December 2017)
                                             October 2016)                                   
  ------------------------------------------ --------------- ------------------------------- -------------------------------
  VAE rate\* (per 1000 ventilator days)      6.8             4.3                             1.3

  VAE rate\* (per 100 ventilated patients)   5.2             3.3                             0.7

  Primary outcomes                                                                           

   Mean MV duration, days (SD)†              7.2 (10.5)      5.5 (6.7)                       4.7 (4.5)

  Balancing measures                                                                         

   No of MV patients per month (SD)‡         16 (3.6)        18 (5.8)                        15 (7.4)

   ICU case severity index (SD)‡             1.09 (0.35)     1.16 (0.17)                     1.10 (0.24)

   Ventilator utilisation ratio§             0.23            0.24                            0.17

  Process measures                                                                           

   % Order for SAT¶                          30%             67%                             68%

   % Order for SBT¶                          51%             73%                             81%
  --------------------------------------------------------------------------------------------------------------------------

\*Negative binomial regression comparison of period 1 with baseline and period 2 with baseline non-significant (p=0.468 and p=0.105, respectively, for VAE rate per 1000 ventilator days; p=0.506 and 0.059, respectively, for VAE rate per 100 ventilated patients).

†ANOVA F-test of baseline, period 1 and period 2 significant (p=0.017), post-test pairwise comparison of period 2 with baseline significant (p=0.049).

‡ANOVA F-test of baseline, period 1 and period 2 non-significant (p=0.647 for MV patients; p=0.894 for ICU case severity index).

§Pearson χ^2^ test of baseline, period 1 and period 2 significant (p\<0.001), post-test pairwise comparison of period 2 with baseline significant (p\<0.001) and comparison of period 2 with period 1 significant (p\<0.001).

¶Pearson χ^2^ test of baseline, period 1 and period 2 significant (p\<0.001), post-test pairwise comparison of period 1 with baseline significant (p\<0.001) and comparison of period 2 with baseline significant (p\<0.001) (for SAT and SBT orders).

ICU, intensive care unit; MV, mechanical ventilation; SAT, spontaneous awakening trial; SBT, spontaneous breathing trial.

Feedback on usability of the revised order set and protocols was mixed. Most residents had such little firsthand experience with the previous order set that it was nearly impossible to compare with the new order set, but none who used the new order set reported issues. Several nurses questioned why fentanyl was not included as a sedative in the SAT protocol and voiced safety concerns, particularly regarding management of patients who became agitated when sedation was held.

Lessons and limitations {#s7}
=======================

In this ventilator bundle implementation project, we found sustained improvements in processes and favourable trends in outcomes. Increases in SAT and SBT order entry were associated with attending physicians reminding residents to order the ventilator bundle, implying the simple but substantial effect attending physicians have on resident behaviour; we believe streamlining the order set in period 2 helped sustain the initial improvement in period 1. Although we did not achieve our goal of decreasing average MV duration to less than 3 days, chart analysis exhibits a clear downward trend and a statistically significant decrease in MV duration using classical statistics. Because of the infrequency of VAEs and downward trend in MV duration starting before our intervention, we cannot definitively attribute decreases in VAE incidence and MV duration to our intervention. However, these changes, coupled with the significant decrease in variation of MV duration associated with our intervention, suggest that standardising ventilator weaning conferred some reduction in MV duration.

One reason we considered for not reaching our goal was varied actualisation of SAT and SBT orders. Preliminary bedside audits of processes downstream to order entry showed RTs consistently performed SBTs when indicated, but there were missed opportunities for SATs. There were far more opportunities for SBTs since all MV patients necessarily need them before extubation. The RT staffing change in March 2017 enabled the SBT protocol's success; the heightened presence of RTs gave them more visibility to other ICU staff and confidence with the SBT protocol. The RT director also noted improvements in RT documentation and empowerment.

Conversely, transitioning from a physician-directed SAT strategy to a nurse-driven SAT protocol was challenging for cultural reasons and also because only half of MV patients had sedative infusion orders and therefore needed SATs. This affected the absolute number of patients eligible for SATs. Based on the size of our ICU (22 beds) and our average ventilator utilisation ratio (0.27), on a given day, we would expect to see six mechanically ventilated patients; furthermore, based on our sedative infusion use (50%), we would expect three of these six patients to be on continuous sedation. Of these three patients, any number of them may have contraindications to the SAT protocol (eg, high oxygenation or vasopressor requirements) resulting in few if any patients eligible for an SAT, in absolute terms. In response to the audit findings showing missed SATs, our ICU nurse educator repeated in-service sessions for nurses to review and answer questions about the protocol. However, many nurses nonetheless voiced safety concerns about the protocol, which ultimately led to its not being accepted. These concerns may be difficult to dispel due to the infrequency of patients needing SATs.

Safety concerns about SAT protocols are not isolated to GLA. According to a national survey of ICU providers, 37% of respondents 'rarely' or never use daily SATs, and 22% of respondents cite lack of nursing acceptance as a barrier.[@R27] Common reasons for providers to hesitate in using SATs include fears of causing agitation or self-extubation. However, randomised trials have only shown slightly higher rates of agitation and self-extubation in MV patients undergoing SATs, with similar reintubation rates.[@R23] Patients who received daily SATs had more ventilator-free days and shorter time to discharge from the ICU and hospital.[@R28] Clearly, safety concerns endure despite evidence of the net benefit of SATs.

Other work has shown the benefit of empowering RTs and nurses to initiate SBTs and SATs, respectively. One randomised clinical trial assessing the impact of RT-led SBTs reduced the average MV duration from 6 to 4.5 days, similar to our findings[@R21]; our interventions, particularly the RT staffing change and SBT protocol in period 2, likely helped contribute to this overall trend towards improvement. Another randomised clinical trial assessing the impact of nurse-led SATs reduced average MV duration from 4.9 to 2.3 days,[@R23] but it is unclear whether additional effort is warranted to promote SATs in GLA's ICU. Admitting diagnosis and degree of physiological derangement have also been associated with MV duration,[@R20] so with GLA's high case severity index, our ability to further reduce MV duration may be small.

Conclusions {#s8}
===========

The ability to reduce VAEs depends on the number of ventilated patients and their MV duration. If few patients are ventilated, and among those few, only some have risks that ventilator bundles address (eg, use of sedative infusions), there may be limited opportunity to decrease VAEs, and the ability to institutionalise recommended practices (eg, SATs) may be more challenging. Ultimately, our improvement team implemented process changes to increase usage of a ventilator bundle, which contributed to improvement in MV duration. Because we now face diminishing marginal returns with standard evidence-based practices, our next steps are to instil broader cultural changes among the ICU staff to increase accountability and teamwork, which will improve processes that affect VAEs and also other elements of care that affect outcomes for critically ill patients.
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